Clinical Studies – Currently Enrolling
If interested, please call Lindsey, Joanne or Melissa at 815-395-9181
Peripheral Artery Disease (PAD)
DURABILITY PAS - A Clinical trial for patients with newly diagnosed PAD. The US StuDy for EvalUation EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem Post Approval Study.
Physicians: Dr. Skowronski, Dr. Minor, Dr. Cook, Dr. Sheikh
GORE ISR 14-04 - A Clinical trial for patients who have already had stents in the legs and are experiencing reoccurring symptoms of PAD. Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis in the Superficial Femoral Artery.
Physicians: Dr. Minor, Dr. Cook, Dr. Skowronski
Preserve II - A Clinical trial for patients with an iliac aneurysm needing treatment. PRESERVE-Zenith® Iliac Branch Clinical Study-Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation.
Physicians: Dr. Cable, Dr. Cook, Dr. Sheikh
AdaptResponse - A Clinical trial for patients with both heart failure and left bundle branch block. The purpose of this clinical study is to test the hypothesis that market released CRT devices which contain the AdaptivCRT® (aCRT) algorithm have a superior outcome compared to standard CRT devices in CRT indicated patients with normal AV conduction and left bundle branch block (LBBB).
Physicians: Dr. Silva, Dr. Dhanekula, Dr. Farokhi, Dr. Hiser, Dr. Telfer
DEEP - A Clinical trial for patients with long standing Atrial Fibrillation that is now symptomatic. Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach for Treatment of Subjects with Persistent or Long Standing Persistent Atrial Fibrillation with Radio-frequency Ablation.
Physicians: Dr. Farokhi, Dr. Cable, Dr. Telfer
Optisure PAS - A Registry for patients who have/will receive an Optisure defibrillator lead. Optisure Lead Study
Physicians: Dr. Farokhi, Dr. Hiser, Dr. Silva
Coronary Artery Disease
ARTEMIS - A Clinical trial for patients who were in the hospital for a STEMI or NSTEMI and will need anticoagulation for 12 months-enrollment must happen prior to discharge. Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study.
Physicians: Dr. Cook, Dr. Minor, Dr. Skowronski, Dr. Isaacson, Dr. Sheikh, Dr. Silva
COMMANDER HF - A Clinical trial for patients with heart failure who have been recently hospitalized due to hearth failure. A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Oral Rivaroxaban with Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects with Chronic Heart Failure and Significant Coronary Artery Disease Following a Hospitalization for Exacerbation of Heart Failure.
Physicians: Dr. Farokhi, Dr. Silva, Dr. Christensen, Dr. Telfer